Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: An administrative claims analysis

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Smoyer Tomic, Karen E ^a   Amato, Anthony A ^b   Fernandes, Ancilla W ^c  

^a THOMSON REUTERS   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; ETHNICITY; FEMALE; HUMAN; INTERSTITIAL MYOSITIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MORBIDITY; MYOSITIS; POLYMYOSITIS; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BIOPSY; CHI-SQUARE DISTRIBUTION; DATA MINING; DATABASES, FACTUAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MEDICAID; MEDICARE PART B; MIDDLE AGED; MYOSITIS; PREVALENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84867900857     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-103     Document Type: Article

References (20)

1. National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health 2010 Available: http://www.ninds.nih.gov/disorders/ inflammatory-myopathies/detail-inflammatory-myopathies.htm
2. The geoepidemiology of autoimmune muscle disease. Prieto S, Grau JM, Autoimmun Rev 2010 9 330 4 10.1016/j.autrev.2009.11.006 19906360
3. Inclusion body myositis: old and new concepts. Amato AA, Barohn RJ, J Neurol Neurosurg Psychiatry 2009 80 1186 93 10.1136/jnnp.2009.173823 19864656
4. Evaluation and treatment of inflammatory myopathies. Amato AA, Barohn RJ, J Neurol Neurosurg Psychiatry 2009 80 1060 1068 10.1136/jnnp.2008.169375 19762898
5. 119th ENMC international workshop.Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. Neuromuscul Disord 2004 14 337 345 10.1016/j.nmd.2004.02.006 15099594
6. Myositis as a cause of muscle pain. Pongratz D, Späth M, Fischer P, J Musculoskeletal Pain 1999 7 121 129 10.1300/J094v07n01-12
7. Dermatomyositis and poly myositis: Clinical presentation, autoantibodies, and pathogenesis. Mammen AL, Ann NY Acad Sci 2010 1184 34 153
8. Idiopathic inflammatory myopathies: Epidemiology, classification, and diagnostic criteria. Mastaglia FL, Phillips BA, Rheum Dis Clin North Am 2002 28 723 741 10.1016/S0889-857X(02)00021-2 12510664
9. Treatment of the inflammatory myopathies: Update and practical recommendations. Hengstman GJD, van den Hoogen FHJ, van Engelen BGM, Expert Opin. Pharmacother 2009 10 1183 1190 10.1517/14656560902913815 19405792
10. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. Wilson FC, Ytterberg SR, St Sauver JL, Reed AM, J Rheumatol 2008 35 445 7 18203321
11. Update on idiopathic inflammatory myopathies. Briani C, Doria A, Sarzi- Puttini P, Dalakas MC, Autoimmunity 2006 39 161 170 10.1080/08916930600622132 16769649
12. Polymyositis and dermatomyositis. Dalakas MC, Hohlfeld R, Lancet 2003 362 971 82 10.1016/S0140-6736(03)14368-1 14511932
13. Treatment of dermatomyositis and polymyositis. Choy EHS, Isenberg DA, Rheumatology 2002 41 7 13 12173280
14. Incidence of polymyositis- dermatomyositis. Oddis CV, Conte CG, Steen VD, Medsger JA, J Rheumatol 1990 17 1329 34 2254890
15. Epidemiology of polymyositis-dermatomyositis in Israel, 1960-76. Benbassat J, Geffel D, Zlotnick A, Isr J Med Sci 1980 16 197 200 7390760
16. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Bernatsky S, Joseph L, Pineau CA, Belisle CA, Boivin JF, Banerjee D, Clarke AE, Ann Rheum Dis 2009 68 1192 96 10.1136/ard.2008.093161 18713785
17. The epidemiology of autoimmune diseases. Cooper GS, Stroehla BC, Autoimmun Rev 2003 2 119 125 10.1016/S1568-9972(03)00006-5 12848952
18. Incidence of dermatomyositis and clinically amyopathic dermatomyositis. Bendewald MJ, Wetter DA, Li X, Davis M, Arch Dermatol 2010 146 26 30 10.1001/archdermatol.2009.328 20083689
19. Epidemiology of idiopathic inflammatory myopathy in a large United States managed care population [abstract]. Furst DE, Amato AA, Iorga SR, Gajira K, Fernandes A, Arthritis Rheum 2011 63 726
20. The incidence of herpes zoster in a United States administrative datablase. Insinga RA, Itzeler RF, Pellissier JM, Saddier P, NIkas AA, J Gen Intern Med 2005 20 748 753 10.1111/j.1525-1497.2005.0150.x 16050886